This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
government's premier research body has made an important discovery that could help create new drugs to lower "bad" cholesterol, and hopefully prevent heartattacks and stroke.
RCE Technologies, Inc. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heartattack detection. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heartattack detection. Featured in an ACC.24
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. Coronary inflammation is a crucial piece of the puzzle in predicting heartattack risk.
Food and Drug Administration ( FDA ) clearance and commercial launch of KAI 12L AI technology and the Kardia 12L ECG System. This is the world’s first AI that can detect life-threatening cardiac conditions, including heartattacks, using a reduced leadset. million ECGs from leading US medical centers.
To diagnose heart conditions including heartattacks and heart rhythm disturbances, clinicians typically rely on 12-lead electrocardiograms (ECGs) -- complex arrangements of electrodes and wires placed around the chest and limbs to detect the heart's electrical activity.
Personalized text messages effectively promoted increased physical activity for patients after significant heart events -- such as a heartattack or surgery -- but those effects later diminished.
Using multiple, serial, intravascular scaffolds, the patented FlexStep Technology combines flexibility with support to open clogged vessels and sustain healthy blood flow while accommodating tortuosity and skeletal movement.
Research Highlights: In a study of patients in a hospital in Taiwan, artificial intelligence technology paired with electrocardiogram testing reduced the time to diagnose and transfer people with heartattacks to the cardiac catheterization laboratory.
Its purpose is to support physicians with a more accurate and personalized risk assessment for patients at risk of major adverse cardiovascular events (MACE), including heartattacks, before they happen. Cleerly is committed to accelerating the availability of its technology to healthcare providers and patients alike.
Following Breakthrough Device Designation granted for the technology by the FDA in 2021, the approval was supported by positive results from the multicenter, prospective, randomized controlled AGENT IDE trial , which enrolled 600 patients at 40 U.S. vs. 3.9%, P=0.001), a 49% risk reduction in heartattack at the target vessel (6.4%
The clipping spline (mesh) is defined by the control points (green) and provides a smooth cutaway view into the looping embryonic mouse heart, revealing the blood flow (orange and blue) in the hearts atrium and ventricle. Faubert and Shang Wang, Stevens Institute of Technology tim.hodson Tue, 01/28/2025 - 10:45 Jan.
2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heartattacks and heart failure. Nicholas S.
I had had a heartattack previously. Technology tools are becoming more sophisticated, bidirectional and disease-specific, and are being designed with home care in mind. After the stroke, I had new prescriptions, and this was the first obstacle for me. I couldn’t dispense my medications into daily doses.
These technologies are not just reshaping but also empowering how cardiology practices manage operations, deliver care, and enhance patient outcomes. These technologies are reshaping how cardiology practices manage operations, deliver care, and enhance patient outcomes.
With its basis in histology, the software is uniquely able to non-invasively quantify and characterize non-calcified plaque and its components such as lipid-rich necrotic core (LRNC), giving potential insights into high-risk plaques that are key drivers of risk of heartattack and stroke. Cardiovasc. 6 (3) (2019).
Participants who were given access to a 5 mg dose of rosuvastatin using this technology-assisted approach experienced a 35.5% LDL or “bad” cholesterol contributes to the development of fatty deposits in the arteries, which raises the risk of heartattacks, strokes and other forms of heart disease.
This condition poses a heightened risk for cardiovascular events, including heartattacks, strokes, and kidney problems. Resistant hypertension occurs when individuals find it challenging to achieve blood pressure control through conventional means, such as lifestyle modifications and multiple antihypertensive medications.
Electrocardiography (ECG) is a diagnostic tool that measures the heart's electrical activity. It is commonly used to diagnose heartattacks, arrhythmias, and other heart conditions. Digital ECG machines use computer technology to record and display the heart's electrical activity.
For the sickest of cardiac patients, those who are leaving the hospital with advanced heart failure or who just had a heartattack, Virtual-First cardiology enables frequent virtual visits driven by AI-driven algorithms which identify the most pressing risks.
Hybrid Conference’ : ‘The RNA vaccines against COVID-19 mark the beginning of a technological revolution that will transform the way we treat disease and restore health. Maybe I should just attend this meeting ‘ The New Frontier of RNA Nanotherapeutic. Monday, October 24, 2022 8:30 a.m. – 5 p.m.
Medical professionals like cardiologists use EKG to diagnose a wide range of heart conditions, such as arrhythmias, heartattacks, and other abnormalities in the heart’s rhythm and function using Einthoven’s Triangle. It then amplifies the signals and records the ECG on graph paper for analysis by Medical Professionals.
A therapy that has been proven repeatedly to reduce the probability of heartattacks and strokes in multiple double-blind randomised controlled studies 1. 9 Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. 2022 Sep 10;400(10355):832-845. J Lipid Res. 2012 Mar;53(3):567-576.
Eighty percent of heartattacks and strokes are preventable. partially because its key risk factor, high blood pressure, is a ‘silent killer,’ and most patients have no symptoms before their first heartattack or stroke. Yet, CVD remains the leading cause of death in the U.S.,
The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed tomography angiography (CCTA) scans to determine the presence, extent and severity of coronary plaques and luminal stenosis (narrowing of arteries). But with AI, we can change that.
a provider of AI technology for coronary artery disease (CAD) management, recently introduced its new brand identity reflecting its focus on delivering clarity, precision and confidence in the prevention, diagnosisand treatment of CAD. CAD is estimated to be responsible for one heartattack every 40 seconds and one out of every five deaths.
Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. We are very excited to see our purpose-driven mission come to life, making advanced cardiac care accessible to more patients and working towards our goal of eliminating heartattacks.” “We
AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions. By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable.
Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology 2. 24: SGLT-2 Inhibitors Show Mixed Results After HeartAttack 10.
Our AI-powered, portable Kardia 12L is AliveCor's first device developed exclusively for use by healthcare providers, paving the way to bring this clinically-validated ECG technology to patients anytime and anywhere." KAI 12L is the world's first AI to detect 35 cardiac determinations, including heartattacks, using a reduced leadset.
mg tablets), together with Caristo Diagnostics , a leading cardiac disease diagnostics company with the novel CaRi-Hearttechnology to visualize and quantify coronary inflammation, announced today their collaboration to improve awareness and clinical education about the central role of inflammation in coronary artery disease.
The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians.
Arrhythmias: Genetic mutations can also predispose individuals to irregular heart rhythms, such as atrial fibrillation or long QT syndrome, which may increase the risk of stroke or sudden cardiac arrest. Gene Editing: Technologies like CRISPR can potentially correct harmful genetic mutations, although this remains largely experimental.
Shockwave is a leading, first-to-market provider of innovative intravascular lithotripsy (IVL) technology for the treatment of calcified CAD and PAD. IVL is a minimally invasive, catheter-based treatment for calcified arterial lesions, which can reduce blood flow and cause pain or heartattack.
Elucid’s PlaqueIQ is the first and only histology-validated FDA-cleared software to non-invasively quantify and characterize non-calcified plaque and its components such as lipid-rich necrotic core (LRNC), giving potential insights into high-risk plaques, key drivers of risk of heartattack and stroke.
Improved patient safety with reduced radiation and contrast load Enhancing patient safety is a pivotal aspect of advanced cardiac imaging technology. By employing advanced scanning technology, healthcare providers can ensure patients undergo diagnostic procedures with minimized risks.
Researchers found an artificial intelligence (AI) system to help guide treatment decisions for stroke patients led to improved stroke care quality and fewer recurrent strokes, heartattacks and vascular death among stroke survivors three months after a stroke. Ischemic stroke is the leading cause of death in China, according to Li.
Family Medicine Specialists' implementation of Cardio Diagnostics' tests in their patient population with CHD risk factors demonstrates the first time a risk-bearing provider is leveraging precision epigenetics-based heart disease technologies with a population health intelligence tool to optimize risk-sharing contracts.
In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. Even with advances in stent technology, patients with coronary in-stent restenosis continue to comprise approximately 10 percent of individuals undergoing angioplasty interventions each year. and Susan F.
milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. Suman Pasupuleti, M.D. billion adults worldwide.
30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. “By
An Overnight Sensation (a century in the making) Efforts to measure the electrical activity of the heart had been well underway since the late 19th Century, though it was the Dutch physiologist Willem Einthoven, improving on these prior developments, who created what we recognize as the ECG.
Do the healthcare clinics have the tools and technologies needed for diagnosing complicated heart conditions? Henceforth, numerous healthcare organizations are stepping forward in bringing a positive change and adopting the latest technologies such as cath lab reporting software, robotic machines for treatments, etc.
Emotional stress and depression affect women’s hearts more profoundly than men’s, and smoking poses a greater risk for women compared to men. Additionally, conditions like diabetes can significantly increase the likelihood of heart disease in women, who may also experience silent heartattacks due to altered pain perception.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content